Haesun Choi, M.D.
Department of Abdominal Imaging, Division of Diagnostic Imaging
About Dr. Choi
Dr. Haesun Choi joined MD Anderson Cancer Center in 1999 as a clinical radiologist. She is specialized in body MRI and CT. Her clinical experience is focused on male and female pelvic MRI, including the prostate, uterus, cervix and rectum, liver imaging, functional MRI including dynamic contrast enhanced (DCE) - MRI, DWI and spectroscopy (MRS). She has extensive clinical experience on prostate MRI parallels with building up a highly successful prostate imaging program at MD Anderson Cancer Center. Over the last 10 years, Dr. Choi has been involved in the development and application of the non-invasive methods for liver fat and iron quatitaion and evaluation of the underlying liver fibrosis and hepatocellular carcinoma. Dr. Choi believes that as an oncologic radiologist, one of the most important contributions in research as well as clinical patient care, is provision of accurate and reliable measures of tumor response, which has lead to develop the so called "Choi Criteria".
Present Title & Affiliation
Primary Appointment
Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Diagnostic and Interventional Imaging, McGovern Medical School, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Diagnostic and Interventional Imaging, McGovern Medical School, Houston, TX
Education & Training
Degree-Granting Education
| 1982 | Hanyang University, Seoul, KR, Medical Science, M.S |
| 1979 | Hanyang University, Seoul, KR, MD |
| 1975 | Hanyang University, Seoul, KR, Science, BS |
Postgraduate Training
| 1989-1991 | Clinical Fellowship, Diagnostic Imaging (CT, US, MRI), The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1987-1989 | Clinical Residency, Diagnostic Radiology, University of South Alabama Medical Center, Mobile, AL |
| 1984-1987 | Clinical Residency, Nuclear Medicine, University of Iowa Hospitals, Iowa City, IA |
| 1980-1984 | Clinical Residency, Internal Medicine, Hanyang University Hospital, Seoul |
| 1979-1980 | Clinical Internship, Hanyang University Hospital, Seoul |
Board Certifications
| 1990 | American Board of Radiology |
| 1987 | American Board of Nuclear Medicine |
| 1983 | Korean Board of Internal Medicine |
Experience & Service
Academic Appointments
Professor, Graduate School of Cancer Science and Policy, National Cancer Center, Seoul, 2015 - 2023
Adjunct Faculty, The University of Texas Graduate School of Biomedical Science, Houston, TX, 2008 - 2013
Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2019
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2008
Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2002
Assistant Professor, Department of Diagnostic Radiology, Baylor College of Medicine, Houston, TX, 1992 - 1999
Administrative Appointments/Responsibilities
Director of Body MRI, Department of Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - 2012
Director of MRI, VA Medical Center, Houston, TX, 1991 - 1999
Other Appointments/Responsibilities
Consultant, Hutchison MediPharma (US) Inc, Florham Park, NJ, 2019 - 2020
Consultant, Arog Pharmaceuticals, Inc, Dallas, TX, 2017 - Present
Consultant, Intrasense, Paris, 2015 - 2017
Imaging Co-Chair, Randomized Phase II Study of High Does Octreotide +/- Radioembolization for Patients with Lover-Dominant Carcinoid, PI - Joshua Meyer, MD, NCI - NET TF, Philadelphia, PA, 2014 - 2017
NCI - NET Task Force Member, ACRIN representative to the Neuroendocrine Tumor (NET) Task Force (TF) of the Gastrointestinal Steering Committee (GISC); National Cancer Institute (NCI), Bethesda, MD, 2014 - 2020
Consultant, Mint Medical, Houston, TX, 2014 - 2016
Consultant, Imaging Endpoints, Houston, TX, 2014 - 2017
ACRIN representative, Eastern Cooperative Oncology Group (ECOG), Philadelphia, PA, 2014 - Present
Investigator (I-52833), Cancer Therapy Investigator Program (CTEP), NCI, Bethesda, MD, 2013 - Present
Imaging Committee Member, Southwest Oncology Group (SWOG) Imaging Committee, San Antonio, TX, 2013 - Present
Consultant, VirtualScopics, Rochester, NY, 2010 - 2013
Consultant, Novartis, Pharm, Basel, Switzerland, 2009 - Present
Panel Member, National Cancer Institute Consensus Meeting on DW-MRI as a Cancer Biomarker, Maryland, MD, 2008
Consultant, Berlex, Wayne, NJ, 2006 - 2008
Board Member, Connective Tissue Oncology Society, Alexandria, VA, 2005 - 2008
Core Faculty, Gastrointestinal Stromal Tumors Continuing Medical Education (CME) Visiting Faculty Program, Health Science Center for CME, New York, NY, 2004 - 2015
Panel Member, European Society for Medical Oncology/National Comprehensive Cancer Network Gastrointestinal Stromal Tumors Consensus Group, Lugano, 2004
Board Member, Gastrointestinal Stromal Tumors Global Strategic Advisory Board, Novartis Oncology, Basel, 2004 - Present
Consultant, Amgen, Inc, Thousand Oaks, CA, 2004 - 2007
Panel Member, National Comprehensive Cancer Network Gastrointestinal Stromal Tumors Consensus Group, Jenkintown, PA, 2003 - 2006
Board Member, Gastrointestinal Stromal Tumors Strategic Advisory Board, Novartis Oncology, Florham Park, NJ, 2003 - 2008
Institutional Committee Activities
Committee Member, The Division of Diagnostic Imaging Faculty Support Group, 2018 - Present
Committee Member, The Division of Diagnostic Radiology QA, 2013 - 2014
Committee Member, Reimbursement Strategies for Prostate Cancer Group, 2013 - 2015
Associate Member, Institutional Review Board 2, 2013 - Present
Committee Member, The Division of Diagnostic Radiology QA, 2011 - 2012
Committee Member, Sarcoma Medical Oncology Chair Search Division of Cancer Medicine, 2011 - 2012
Supervisory Committee Member, The University of Texas Graduate School of Biomedical Science, 2008 - 2013
Committee Member, The Division of Diagnostic Radiology QA, 2007 - Present
Chair, Body MRI Protocol Committee, 1999 - 2012
Honors & Awards
| 2012 - 2013 | Distinguished Reviewer of JMRI, Journal of Magnetic Resonance Imaging |
| 2012 | Certificate of Merit, Radiological Society of North America |
| 2011 | Distinguished Reviewer of JMRI, Journal of Magnetic Resonance Imaging |
| 2011 | Highlighted in the press program for the Cancer Imaging and Radiation Therapy Symposium, American Society for Radiation Oncology |
| 2011 | JCO's Top-Cited Authors "Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria", Journal of Clinical Oncology |
| 2011 | JCO's Top-Cited Authors "We should desist using RECIST, at least in GIST.", Journal of Clinical Oncology |
| 2010 | Cum Laude Award, Radiological Society of North America |
| 2007 | Certificate of Merit, American Roentgen Ray Society |
| 2006 | Second Place, International Society for Magnetic Resonance in Medicine |
| 2006 | Third Place, Selection for Magnetic Resonance Technologists |
| 2004 | Certificate of Merit, Radiological Society of North America |
| 2000 | Cum Laude Award, Radiological Society of North America |
| 1979 | Dean's Award, Hanyang University School of Medicine |
| 1978 | Nockshipja Scholarship Award, Nockshipja |
| 1976 - 1979 | University Scholarships for the Honor Students, Hanyang University |
| 1974 - 1975 | University Scholarships for the Honor Students, Hanyang University |
| 1974 | Honor from the President, Hanyang University |
| 1973 | University Scholarships for the Honor Students, Hanyang University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Boss MA, Snyder BS, Kim E, Flamini D, Englander S, Sundaram KM, Gumpeni N, Palmer SL, Choi H, Froemming AT, Persigehl T, Davenport MS, Malyarenko D, Chenevert TL, Rosen MA. Repeatability and reproducibility assessment of the apparent diffusion Coefficient in the prostate: A trial of the ECOG-ACRIN research group (ACRIN 6701). J Magn Reson Imaging 56(3):668-679, 2022. e-Pub 2022. PMID: 35143059.
- Altok M, Demirel C, Kang HC, Choi H, John D, Inguillo IA, Davis JW, Ward JF. Impact of MRI/US fusion-guided prostate biopsy on biopsy-naïve patients: A single urologist's experience. BJUI Compass 3(1):19-25, 2022. e-Pub 2022. PMID: 35475153.
- Tang C, Msaouel P, Hara K, Choi H, Le V, Shah AY, Wang J, Jonasch E, Choi S, Nguyen QN, Das P, Prajapati S, Yu Z, Khan K, Powell S, Murthy R, Sircar K, Tannir NM. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol 22(12):1732-1739, 2021. e-Pub 2021. PMID: 34717797.
- Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol 39(9):3259-3264, 2021. e-Pub 2021. PMID: 33454813.
- Kang HC, Jo N, Bamashmos AS, Ahmed M, Sun J, Ward JF, Choi H. Accuracy of prostate magnetic resonance imaging: reader experience matters. Eur Urol Open Sci 27:53-60, 2021. e-Pub 2021. PMID: 33899028.
- Urkmez A, Ward JF, Choi H, Troncoso P, Inguillo I, Gregg JR, Altok M, Demirel HC, Qiao W, Kang HC. Temporal learning curve of a multidisciplinary team for magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy. BJU Int 127(5):524-527, 2021. e-Pub 2021. PMID: 33340435.
- Shapiro DD, Gregg JR, Lim AH, Nogueras-González GM, Choi H, Kang HC, Inguillo IA, Chapin BF, Davis JW, Ward JF. Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance. BJU Int 127(3):340-348, 2021. e-Pub 2021. PMID: 32357283.
- Gupta S, Kang HC, Sun J, Matrana MR, Tannir NM, Choi H. Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC). Abdom Radiol (NY) 45(6):1872-1882, 2020. e-Pub 2020. PMID: 31822966.
- Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, Eng C, Maru DM, Ychou M, Vauthey JN, Loyer EM, Kopetz S. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut 67(6):1095-1102, 2018. e-Pub 2018. PMID: 29084828.
- Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: Efficacy, toxicity, and quality of life outcomes. Int J Radiat Oncol Biol Phys 100(2):374-382, 2018. e-Pub 2018. PMID: 29229325.
- Kang HC, Gupta S, Wei W, Lu L, Matrana MR, Tannir NM, Choi H. Alternative response criteria and clinical risk factors for assessing tumor response in patients with metastatic renal cell carcinoma who are receiving salvage therapy. AJR Am J Roentgenol 209(6):1278-1284, 2017. e-Pub 2017. PMID: 29064751.
- Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) 19(8):706-712, 2017. e-Pub 2017. PMID: 28528267.
- Choi H. Role of imaging in response assessment and individualised treatment for sarcomas. Clin Oncol (R Coll Radiol), 2017. e-Pub 2017. PMID: 28506521.
- Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra PA, Reyners AK, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients. Eur J Cancer 76:76-83, 2017. e-Pub 2017. PMID: 28284172.
- Hunter LA, Chen YP, Zhang L, Matney JE, Choi H, Kry SF, Martel MK, Stingo F, Liao Z, Gomez D, Yang J, Court LE. NSCLC tumor shrinkage prediction using quantitative image features. Comput Med Imaging Graph 49:29-36, 2016. e-Pub 2016. PMID: 26878137.
- Atri M, Zhang Z, Marques H, Gorelick J, Harisinghani M, Sohaib A, Koh DM, Raman S, Gee M, Choi H, Landrum L, Mannel R, Chuang L, Yu JQ, McCourt CK, Gold M. Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: results of ACRIN 6671/GOG 0233. European J Radiol Open 2:11-18, 2015. e-Pub 2015. PMID: 25774381.
- Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol 4(6):e239-46, 2014. e-Pub 2014. PMID: 25407875.
- Choi H, Underwood M, Boonsirikamchai P, Matin S, Troncoso P, Ma J. Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience. Quant Imaging Med Surg 4(4):251-8, 2014. e-Pub 2014. PMID: 25202660.
- Rauch GM, Kaur H, Choi H, Ernst RD, Klopp AH, Boonsirikamchai P, Westin SN, Marcal LP. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer. Radiographics 34(4):1082-98, 2014. e-Pub 2014. PMID: 25019443.
- Hunter LA, Krafft S, Stingo F, Choi H, Martel MK, Kry SF, Court LE. High quality machine-robust image features: identification in non-small cell lung cancer computed tomography images. Med Phys 40(12):121916, 2013. e-Pub 2013. PMID: 24320527.
- Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-9, 2013. e-Pub 2013. PMID: 24059396.
- Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, Choi H. MR imaging of prostate cancer in radiation oncology: what radiologists need to know. Radiographics 33(3):741-61, 2013. e-Pub 2013. PMID: 23674772.
- Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: trends and advances. World J Radiol 5(3):126-42, 2013. e-Pub 2013. PMID: 23671749.
- Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Lor Randall R, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS. Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother 61(7):1113-24, 2012. e-Pub 2012. PMID: 22198309.
- Boonsirikamchai P, Kaur H, Kuban DA, Jackson E, Hou P, Choi H. Use of maximum slope images generated from dynamic contrast-enhanced magnetic resonance imaging to detect locally recurrent prostate carcinoma following prostatectomy - a practical approach. AJR Am J Roentgenol 198(3):W228-236, 2012. e-Pub 2012. PMID: 22358019.
- Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res 2(1):2, 2012. e-Pub 2012. PMID: 22587772.
- Hou P, Popat UR, Lindsay RJ, Jackson EF, Choi H. A practical approach for a wide range of liver iron quantitation using a magnetic resonance imaging technique. Radiol Res Pract 2012:207391, 2012. e-Pub 2012. PMID: 23365743.
- Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of Temozolomide and Bevacizumab in the treatment of locally advanced recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 117(21):4939-47, 2011. e-Pub 2011. PMID: 21480200.
- Oh JY, Cho JH, Kang MJ, Lee JH, Kwon HJ, Nam KJ, Kim MC, Choi H. Omental infarction caused by laparoscopy-assisted gastrectomy for gastric cancer: CT findings. Clin Radiol 66(10):966-973, 2011. e-Pub 2011. PMID: 21684534.
- Asran MK, Loyer EM, Kaur H, Choi H. Case 177. Radiology 260(3):908-910, 2011. e-Pub 2011.
- Kaur H, Matin SF, Javadi S, Johnson VE, Choi H, Sandler C, Ahrar K. Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 22(7):924-7, 2011. e-Pub 2011. PMID: 21507680.
- Mohamed AA, Kaur H, Loyer E, Choi H. Diagnosis please: Case 177. Radiology 260(3):908-910, 2011. e-Pub 2011.
- McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, phase II study of preoperative plus postoperative Imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 16(4):910-919, 2009. e-Pub 2009. PMID: 18953611.
- Bhosale P, Ma J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: self-assessment module. AJR Am J Roentgenol 192:S94-S97, 2009. e-Pub 2009.
- Weinreb J C, Blume D, Coakley F V, Wheeler T M, Cormack J B, Sotto C K, Choi H, Kawashima A, Tempany-Afdahl C M, Macura K J, Rosen M, Gerst S R, Kurhanewicz J. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 251(1):122-133, 2009. e-Pub 2009.
- Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-836, 2008. e-Pub 2008. PMID: 18488000.
- Choi H, Ma J. Use of perfluorocarbon compound in the endorectal coil to improve MR spectroscopy of the prostate. AJR Am J Roentgenol 190(4):1055-1059, 2008. e-Pub 2008. PMID: 18356455.
- Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer 122(3):711-718, 2008. e-Pub 2008. PMID: 17943734.
- Ma J, Son JB, Zou Y, Le-Petross H, Choi H. Fast spin echo triple echo Dixon (fTED) technique for efficient T2-weighted water and fat imaging. Magn Reson Med 58(1):103-109, 2007. e-Pub 2007. PMID: 17659631.
- Nagle CE. Choi Criteria vs. RECIST in GIST. J Nucl Med 48(7):40N, 2007. e-Pub 2007.
- Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We should desist using RECIST, at least in GIST. J Clin Oncol 25(13):1760-1764, 2007. e-Pub 2007. PMID: 17470866.
- Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography (CT) and positron emission tomography (PET) in patients with metastatic GIST treated at a single institution with imatinib mesylate: proposal of new CT response criteria. J Clin Oncol 25(13):1753-1759, 2007. e-Pub 2007. PMID: 17470865.
- Li C, Liengsawangwong R, Choi H, Cheung R. Using a prior structural information from magnetic resonance imaging to investigate the feasibility of prostate diffuse optical tomography and spectroscopy: a simulation study. Med Phys 34(1):266-274, 2007. e-Pub 2007. PMID: 17278512.
- Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Cancer 107(9):2237-2244, 2006. e-Pub 2006. PMID: 16998931.
- Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate. Cancer 106(7):1617-1623, 2006. e-Pub 2006. PMID: 16518826.
- Ma J, Vu AT, Son JB, Choi H, Hazle JD. Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI. J Magn Reson Imaging 23(1):36-41, 2006. e-Pub 2006. PMID: 16315212.
- Ma J, Son JB, Bankson JA, Stafford RJ, Choi H, Ragan D. A fast spin echo two-point Dixon technique and its combination with sensitivity encoding for efficient T2-weighted imaging. Magn Reson Imaging 23(10):977-982, 2005. e-Pub 2005. PMID: 16376180.
- Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF, Breaux AJ, Kuban DA. Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol 28(6):618-625, 2005. e-Pub 2005. PMID: 16317275.
- Kavanagh JJ, Gershenson DM, Choi H, Lewis L, Patel K, Brown GL, Garcia A, Spriggs DR. Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer. Int J Gynecol Cancer 15(4):593-600, 2005. e-Pub 2005. PMID: 16014111.
- Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PCW, Joensuu H, Le Cesne A, MacClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16(4):566-578, 2005. e-Pub 2005. PMID: 15781488.
- Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183(6):1619-1628, 2004. e-Pub 2004. PMID: 15547201.
- Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 64(17):5913-5919, 2004. e-Pub 2004. PMID: 15342366.
- Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239(4):450-458, 2004. e-Pub 2004. PMID: 15024305.
- Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, Broemeling LD, Cleary KR, Charnsangavej C. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182(3):619-623, 2004. e-Pub 2004. PMID: 14975959.
- Ma J, Choi H, Stafford RJ, Miller MJ. Silicone-specific imaging using an inversion-recovery-prepared fast three-point Dixon technique. J Magn Reson Imaging 19(3):298-302, 2004. e-Pub 2004. PMID: 14994297.
- Demetri GD, Benjamin R, Blanke CD, Choi H, Corless C, DeMatteo RP, Eisenberg BL, Fletcher CDM, Maki RG, Rubin B, Van den Abbeele AD, von Mehren M. NCCN task force report: optimal management of patients with gastrointestinal stromal tumors (GIST) – expansion and update of NCCN Clinical Practice Guidelines. J Natl Compr Canc Netw 2(Suppl 1), 2004. e-Pub 2004.
- Choi H, David CL, Katz RL, Podoloff D. Case 69. Radiology 229(3):724-725, 2003. e-Pub 2003.
- Choi H, Loyer E, Dubrow R, Kaur H, David C, Huang S, Curley S, Charnsangavej C. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21 Spec:S41-S54, 2001. e-Pub 2001. PMID: 11598247.
- Netscher D, Mosharrafa A, Lee M, Polsen C, Choi H, Steadman AK, Thornby J. Transverse carpal ligament: its effect on flexor tendon excursion, morphologic changes of the carpal canal, and on pinch and grip strengths after open carpal tunnel release. Plast Reconstr Surg 100(3):636-642, 1997. e-Pub 1997. PMID: 9283561.
- Netcher D, Polsen C, Thornby J, Choi H, Udeh J. Anatomic delineation of the ulnar nerve and ulnar artery in relation to the carpal tunnel by axial magnetic resonance imaging scanning. J Hand Surg 21(2):273-276, 1996. e-Pub 1996.
- Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 157(2):353-358, 1991. e-Pub 1991. PMID: 1853821.
- Choi H, Karim R, Bruch P, Boyd S, Marcus M, Kirchner PT. Quantitation of Thallium 201 kinetics after dipyridamole in normal volunteers. Am J Card Imaging 3(4):299-307, 1989. e-Pub 1989.
- Choi H, Choi IY, Chung HS. A case of lymphoblastic lymphoma. Korean J Hematol 17:79, 1982. e-Pub 1982.
- Lee DH, Choi H, Kim SK, Hahn SW, Park KS, Park KN. Ultrasonographic demonstration of intestinal obstruction. Korean Soc Med Ultrasound 1:17, 1982. e-Pub 1982.
- Choi H, Sohn LJ, Lee DH, Sohn ES. Clinical observation on antihypertensive effects of Atenolol (Tenormin). J Korean Am Med Assoc 24:818, 1982. e-Pub 1982.
- Park YK, Choi H, Lee YK, Lee BH, Lee DH, Kee CS, Park KN. Serum gastrin analysis of the patients with peptic ulcer disease and stomach cancer. Korean J Intern Med 25:1, 1982. e-Pub 1982.
- Sohn ES, Lee DH, Lee BH, Choi H. Cardiovascular disease and its risk factors in Korea. Jpn Circ J 46:601, 1982. e-Pub 1982.
- Seok SE, Park CH, Nam SH, Choi H, Lee JI, Lee DH, Huh BY, Sohn ES. An experimental study on the antihypertensive effect of Korean ginseng to spontaneously hypertensive rats (SHR) in labile stage of hypertension. J Korean Am Med Assoc 24:509, 1981. e-Pub 1981.
Invited Articles
- Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32(2):389-409, 2012. e-Pub 2012. PMID: 22411939.
- Boonsirikamchai P, Loyer EM, Choi H, Charnsangavej C. Planning and follow-up after ablation of hepatic tumors: imaging evaluation. Surg Oncol Clin N Am 20(2):301-315, 2011. e-Pub 2011. PMID: 21377585.
- Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib1. Radiographics 26(2):481-495, 2006. e-Pub 2006. PMID: 16549611.
- Choi H. Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 7(4):307-311, 2005. e-Pub 2005. PMID: 15946591.
- Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS. Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep 7(4):293-299, 2005. e-Pub 2005. PMID: 15946589.
- Faria SC, Tamm EP, Loyer EM, Szklaruk J, Choi H, Charnsangavej C. Diagnosis and staging of the pancreatic tumors. Semin Roentgenol 39(3):397-411, 2004. e-Pub 2004. PMID: 15372753.
- Choi H, Loyer EM, Charnsangaveg C. Neoplasms of the liver and bile ducts. Semin Roentgenol 39(3):412-427, 2004. e-Pub 2004. PMID: 15372754.
- Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. Radiographics 23(2):403-424, 2003. e-Pub 2003. PMID: 12640156.
- Charnsangavej C, Loyer EM, Iyer RB, Choi H, Kaur H. Tumors of the liver, bile duct, and pancreas. Curr Probl Diagn Radiol 29(3):69-107, 2000. e-Pub 2000. PMID: 10875047.
Manuals, Teaching Aids, Other Teaching Publications
- Choi H. Body MRI Protocol Manual (1.5T and 3T). The University of Texas MD Anderson Cancer Center, 2012.
- Choi H. Body MRI Protocol Manual (1.5T). The University of Texas MD Anderson Cancer Center, 2008.
- Choi H. Body MRI Protocol Manual (1.5T and 3T). The University of Texas MD Anderson Cancer Center, 2007.
- Choi H. The Era of Molecular Therapy: Redefining the Treatment of Gastrointestinal Stromal Tumors (GIST). Update. Health Science Center for CME, 2006.
- Choi H. The Era of Molecular Therapy: Redefining the Treatment of Gastrointestinal Stromal Tumors (GIST). Health Science Center for CME, 2005.
- Choi H. Body MRI Protocol Manual (1.5T and 3T). The University of MD Anderson Cancer Center, 2004.
- Choi H. Radiology Procedure Manual. VA Medical Center, 1999.
- Choi H. MRI Procedure Manual. VA Medical Center, 1991.
Other Articles
- Tang, C, Msaouel, P, Hara, K, Choi, H, Le, V, Shah, AY, Wang, J, Jonasch, E, Choi, S, Nguyen, Q, Das, P, Prajapati, S, Yu, ZH, Khan, K, Powell, SF, Murthy, R, Sircar, K, Tannir, NM Definitive Radiotherapy in Lieu of Systemic Therapy for Oligometastatic Renal Cell Carcinoma: A Single-Arm, Single-Centre, Feasibility, Phase 2 Trial. Journal of Urology 208(1):210, 2022. PMID: 35469446.
- Asran MK, Loyer EM, Kaur H, Choi H Case 177: congenital absence of the portal vein with hepatic adenomatosis. Radiology 262(1):364-7, 2012. PMID: 22190661.
- Choi H Imaging modalities of gastrointestinal stromal tumors. J Surg Oncol 104(8):907-914, 2011. PMID: 22069176.
- Marcal L, Nothaft MA, Coelho F, Choi H Deep pelvic endometriosis: MR imaging. Abdom Imaging 35(6):708-715, 2010. PMID: 20390267.
- Bhosale P, Ma J, Choi H Utility of the FIESTA pulse sequence in body oncologic imaging: review. AJR Am J Roentgenol 192(6 Suppl):S83-S93, 2009. PMID: 19458102.
- Boonsirikamchai P, Podoloff DA, Choi H Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy. Hematol Oncol Clin North Am 23(1):35-48, 2009. PMID: 19248969.
- Choi H Response evaluation of gastrointestinal stromal tumors. Oncologist 13(Suppl 2):4-7, 2008. PMID: 18434631.
- Kundra V, Silverman PM, Matin M, Choi H Imaging in oncology from the University of Texas MD Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol 189(4):830-844, 2007. PMID: 17885053.
- Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST) - update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5(Suppl 2):S1-29; quiz S30, 2007. PMID: 17624289.
- Kwek JW, Choi H, Ma J, Miller MJ Gel-gel double-lumen silicone breast implant: mimic of intracapsular implant rupture. AJR Am J Roentgenol 187(4):W436-W437, 2006. PMID: 16985119.
- Choi H, David CL, Katz RL, Podoloff DA Diagnosis please case 69: extramedullary hematopoiesis. Radiology 231(1):52-56, 2004. PMID: 14990806.
- Choi H, Whitman G, Ro J, Charnsangavej C Benign schwannoma in the porta hepatis. AJR Am J Roentgenol 177(3):652, 2001. PMID: 11517064.
Abstracts
- Pieretti A, Kang H, Choi H, Zhang M, Chapin B, Ward J, Troncoso P, Gregg J. Using magnetic resonance imaging to define focal therapy templates in patients with intermediate-risk prostate cancer. J Urol 207(Supplment 5):E937, 2022. e-Pub 2022.
- Kennady EH, Kang H, Choi H, Akorede A, Davis JW, Pisters L, Pettaway C, Chapin BF, Ward JF, Gregg JR. Determining clinical outcomes among men with a high-risk prostate MRI and negative fusion biopsy. Society of Urologic Oncology 22nd Annual Meeting, 2021. e-Pub 2021.
- Borregales L, Gregg J, Choi H, Lozano M, McRae SE, Venkatesan AM, Gonzalez GN, Davis J, Pisters L, Ward J. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. 2020 Journal of Urology Meeting 203(Suppl 4):E1060, 2020. e-Pub 2020.
- Jo N, Vining DJ, Choi H. Improving communication between radiologists, pathologists, and urologists by using a PI-RADS structured reporting system. 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2019. e-Pub 2019.
- Demireal C, Altok M, Kang H, Choi H, Andres J, Familar E, Davis J, Ward J. MRI-TRUS fusion prostate biopsies: learning curve experience with a multidisciplinary team approach. American Urological Association Annual Meeting 199(45 supplement):e525-E526, 2018. e-Pub 2018.
- Farag S, Somaiah N, Choi H, Heeres B, Wang WL, Van Boven H, Nederlog PM, Benjamin RS, van der Graaf WTA, Grunhagen DJ, Boonstra P, Reyners AKL, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicenter observational cohort of pdgfra exon 18 mutated gastrointestinal stromal tumor (GIST) patients. 2016 American Society of Clinical Oncology Annual Meeting 34(15_suppl):11011, 2016. e-Pub 2016.
- Son JB, Shin S, Noeske R, Bayram E, Ma J, Choi H. Prostate MRSI with reduced acquisition time and improved multichannel spectral processing. Proceedings of the ISMRM 24th Annual Meeting and Exhibition, 2016. e-Pub 2016.
- Lindsay R, Saliba RM, Choi H, Ping H, Ramlal R, Alousi A, Jones R, Champlin R, Popat U. Transfusion history is the most significant predictor of iron overload after allogeneic stem cell transplantation. 2016 BMT Tandem Meeting 22(3):S336-S337, 2016. e-Pub 2016.
- Kaur H, Taggart MW, Shin S, Ernst RD, Loyer EM, Aloia TA, Sharma R, Choi H. Atypical imaging presentations of focal nodular hyperplasia with radiologic pathologic correlation. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2013. e-Pub 2013.
- Hunter L, Chen Y, Zhang L, Matney J, Stingo F, Kry S, Martel M, Choi H, Liao Z, Gomez D, Court L. TU-A-WAB-11: Tumor shrinkage prediction using CT image features. 55th Annual Meeting of the American Association of Physicists in Medicine 40(6):424-425, 2013. e-Pub 2013.
- Hunter L, Stingo F, Kry S, Martel M, Choi H, Court L. WE-G-500-01: Identification of high quality machine-robust CT image features 40(6):503, 2013. e-Pub 2013.
- Sabir SH, McRae SE, Ward JF, Choi H, Wallace MJ. Transgluteal MR-guided prostate biopsy: results of a freehand technique in a closed 1.5T MRI. (SIR) Society of Interventional Radiology 38th Annual Scientific Meeting 24(4 - Supplement):S176-S177, 2013. e-Pub 2013.
- Aloia TA, Zimmitti G, Ma J, Hou P, Rashid A, Curley SA, Vauthey J, Choi H. Non-Invasive preoperative quantification of hepatic steatosis using a novel MRI technique: 100% accuracy confirmed with pathologic assessment. Special Issue: Abstracts of the Thirteenth Annual Americas Hepato-Pancreato-Biliary Congress 2013 15(S1):2, 2013. e-Pub 2013.
- Kaur H, Uribe E, Choi H, Loyer EM. Strengths and limitations of extravascular and liver specific contrast agents in the evaluation of liver lesions. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012. e-Pub 2012.
- Kaur H, Sagebiel TL, You YN, Hou P, Choi H. Preoperative staging of primary rectal tumors: roles of thin section multiplanar 2D T2 FSE imaging, 3D CUBE and diffusion-weighted imaging. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012. e-Pub 2012.
- Choi H, Kuban D, Ward J, Kaur H. Clinically relevant personalized prostate imaging: how do we do?. 98th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012. e-Pub 2012.
- Rauch GM, Ernst RD, Marcal LP, Choi H, Chang GJ, You YN, et al. Role of the high-resolution MRI in the presurgical evaluation of low rectal tumors. 97th Scientific Assembly & Annual Meeting, 2011. e-Pub 2011.
- Ernst RD, Kaur H, Rauch GM, Chang GJ, You YN, Choi H, Skibber JM. Key findings in rectal cancer with emphasis on 3 T MRI. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011. e-Pub 2011.
- Kaur H, Loyer E, Charnsangavej C, Choi H. New paradigm for response evaluation of solid tumors in the era of targeted therapy: comparison with traditional size-based response criteria. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011. e-Pub 2011.
- Rauch GM, Marcal LP, Ernst RD, Boonsirikamchai P, Klopp A, Choi H, Kaur H. Optimization of high-resolution MRI technique for pretreatment staging of the cervical and endometrial cancer. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011. e-Pub 2011.
- Jensen CT, Rauch GM, You YN, Chang GJ, Choi H, Skibber JM, Ernst RD. Mucinous adenocarcinoma of the rectum: disease patterns and pitfalls. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011. e-Pub 2011.
- Kaur H, Thomas A, Jensen C, Bronstein Y, Vauthey JN, Choi H, Loyer E. Biliary invasion in colorectal metastasis: diagnostic criteria on CT and clinical significance. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011. e-Pub 2011.
- Hou P, Popat U, Lindsay R, Jackson E, Choi H. MO-F-211-03: A practical approach for liver iron measurement in clinical setting. 2011 Joint AAPM/COMP Meeting 38(6 - Part 27), 2011. e-Pub 2011.
- Gao J, McAuliffe JC, Lazar AJF, Wang W, Choi H, Hunt K, Araujo M, Pollock RE, Benjamin RS, Trent JC. Mechanism of early radiographic response to imatinib in GIST. 2011 ASCO Annual Meeting 29(10049), 2011. e-Pub 2011.
- Reynoso D, Alicie B, Yang D, Dumont A, Conley A, McAuliffe J, Choi H, Lazar A, Miyashita T, Rubin B, Zhang W, Trent J. BIM upregulation correlates with apoptosis in gastrointestinal stromal tumor patients treated with imatinib. 102nd AACR Annual Meeting, 2011. e-Pub 2011.
- Ernst R, Kaur H, You YN, Rodriguez-Bigas M, Choi H. Structured reporting for MRI staging of rectal cancer. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2010. e-Pub 2010.
- Choi H, Boonsirikamchai P, Kaur H, Johnson V, Underwood M, Ma J. Factors affecting, and possible ways for improving, the prostate MR spectroscopic quality: a single institution experience, 2008. e-Pub 2008.
- Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Choi H, Benjamine RS, Araujo DM. Combination therapy with temozolomide and bevacizumab in the treatment of hemangiopericytoma/malignant solitary fibrous tumor. American Society of Clinical Oncology Annual Meeting 26(suppl 15), 2008. e-Pub 2008.
- Bhosale P, Choi H, Ma J. Utility of FIESTA sequence in day to day MRI imaging. 107th Annual Meeting of the American Roentgen Ray Society, 2007. e-Pub 2007.
- Benjamin RA, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Chuslip C. Response of gastrointestinal stromal tumors (GISTs) to imatinib by Choi criteria and response evaluation criteria in solid tumors (RECIST) as surrogates for survival and time to progression. American Society of Clinical Oncology Annual Meeting Proceedings Part I 24(18 Suppl), 2006. e-Pub 2006.
- Tamm E, Szklaruk J, Iyer RB, Choi H, Lano EA, Holmes R. Online tools for collaboration between radiologists and clinicians in a PACS environment. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2004. e-Pub 2004.
- Choi H, Zhou X, Ma J. Use of perfluorocarbon in magnetic resonance spectroscopy (MRS) of prostate: a method to improve the linewidth and quality of spectra. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2004. e-Pub 2004.
- Brown GL, Lewis L, Choi H, Iyer R, Moore C, Valmonte A, Jameson A, Keck J, Patel K, Kavanagh J. Phase 1-2a dose ranging study of TLK286 (a novel glutathione analog) in combination with liposomal doxorubicin in platinum refractory or resistant ovarian cancer. (#5062). American Society of Clinical Oncology Annual Meeting Proceedings (Post-Meeting Edition) 22(14 Suppl), 2004. e-Pub 2004.
- Kavanagh L, Lewis L, Choi H, Iyer R, Moore C, Jameson A, Keck J, Parra R, Patel K, Brown GL. Phase 1-2a study of TLK286 (a novel glutathione analog) in combination with carboplatin in platinum refractory or resistant (3rd line) ovarian cancer. American Society of Clinical Oncology Annual Meeting Proceedings (Post-Meeting Edition) 22(14 Suppl), 2004. e-Pub 2004.
- Marcal L, Choi H, Jackson E, Benjamin RS, Rashid A. Use of quantitative dynamic contrast MR imaging to monitor musculoskeletal sarcomas: correlation with FDG PET and pathology. International Society for Magnetic Resonance in Medicine, 12th Scientific Meeting and Exhibition, 2004. e-Pub 2004.
- Ma J, Choi H, Stafford JR. Dynamic study of sarcoma with reduced-encoding imaging by generalized-series reconstruction. ISMRM 11th Scientific Meeting & Exhibition:258, 2003. e-Pub 2003.
- Benjamin RS, Choi H, Charnsangavej C, Macapinlac HA, Burgess MA, Chen LL, Trent JC, Patel SR. Should desist using recist, at least in GIST. 8th Annual Meeting, Connective Tissue Oncology Society, 2003. e-Pub 2003.
- Ma J, Choi H, Stafford JR. Silicone prosthesis imaging using an inversion recovery fast spin echo and fast Dixon technique. ISMRM 11th Scientific Meeting & Exhibition, 2003. e-Pub 2003.
- Choi H, Charnsangavej C, Macapinlac HA, Burgess M, Patel S, Chen L, Podoloff D, Benjamin R. Correlation of CT and PET in patients with metastatic GIST treated at a single institution with Imatinib Mesylate 22, 2003. e-Pub 2003.
- Tang C, Sherry AD, Seo A, Kobayashi K, Choi H, Liu S, Sun X, Montoya AM, Ludmir EB, Shah AY, Zurita-Saavedra, A, Kovitz CA, Genovese G, Sircar K, Karam JA, Tammir NM, Msaouel P, Battey C, Ratzel S, Muzzey D, Jasper J. Phase 2 trial of metastasis directed radiotherapy without systemic therapy (MRWS) for oligometastatic clear cell renal cell carcinoma (ccRCC) and investigation of circulating tumor DNA (ctDNA) as a personalized biomarker. The American Association for Cancer Research (AACR).
Book Chapters
- Choi H. Radiotherapy in practice: imaging in clinical oncology. In: Gastrointestinal Stromal Tumor. 2nd. Oxford University Press, 2021.
- Shin S, Choi H. Imaging and response evaluation of gastrointestinal stromal tumors. In: Gastrointestinal Stromal Tumors. Springer, Cham, 73-89, 2017.
- Choi H. Traditional size-based response evaluation criteria in solid tumors (RECIST) and new evidence based response evaluation criteria (Choi Criteria) in sarcoma. In: Sarcoma Oncology: A Multidisciplinary Approach. 1st. People's Medical Publishing House, 2016.
- Choi H, Loyer EM, Kaur H, Silverman PM. Imaging neoplasms of the abdomen and pelvis. In: Cancer Medicine 7. B.C. Decker Inc.: Baltimore, 474-478, 2005.
- Choi H, Loyer EM, Charnsangavej C. Radiographic imaging following radiofrequency ablation of liver tumors. In: Radiofrequency Ablation for Cancer. 1. Springer, 253-267, 2004.
- Choi H, Loyer EM, Charnsangavej C. Imaging assessment following radiofrequency ablation of liver tumors. In: Radiofrequency Ablation of Cancer Current Indications, Techniques and Outcomes. Springer: New York, 2003.
- Choi H, Loyer EM, Kaur H, Silverman PM. Imaging neoplasms of the abdomen and pelvis. In: Cancer Medicine 6. B. C. Decker, Inc.: Baltimore, 523-527, 2003.
Letters to the Editor
- Choi H, Charnsangavej C, Faria SC, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA. CT Evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. Letter and Reply. Drs. Choi and Johnson respond. AJR Am J Roentgenol 185: 1366-1367, 2005.
Selected Presentations & Talks
Local Presentations
- 2014. Response evaluation of solid tumors – "Choi" criteria and beyond. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Response evaluation of solid tumors – "Choi” criteria. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2013. Prostate - MR Staging and post-treatment assessment. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2012. Response evaluation of solid tumors - "Choi" criteria. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2012. Case Review. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2011. Imaging for prostate cancer: what's new?. Invited. 6th Urologic Oncology: Advances in Clinical Practice. Houston, TX, US.
- 2011. Choi Criteria. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2011. Development of an ultrafast MRI sequence for improved dynamic liver imaging. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2009. Responding or not responding: lessons from GIST model. Conference. GIST Support International and The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2009. Response assessment and radiology of GIST. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2009. Imaging response: RECIST and beyond. Conference. International Thyroid Oncology Group (The University of Texas MD Anderson Cancer Center). Houston, TX, US.
- 2009. Prostate imaging. Conference. The Prostate Cancer Teaching Module for Urology Fellows/Residents (The University of Texas MD Anderson Cancer Center). Houston, TX, US.
- 2004. Role of MR spectroscopy in prostate cancer. Conference. TEX US TOO (Houston Division). Houston, TX, US.
- 2002. Radiofrequency (RF) ablation of liver tumors: assessment of therapeutic response and complications. Conference. American Radiological Nurses Association. Houston, TX, US.
Regional Presentations
- 2003. New directives in prostate cancer therapy. Conference. Eleventh Annual Radiation Workshop (The University of Texas MD Anderson Cancer Center). Round Top, TX, US.
National Presentations
- 2019. Improving communication between radiologists, pathologists, and urologists by using a PI-RADS structured reporting system. Conference. 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2019. MRI based selection for fusion prostate biopsy - interpretation. Invited. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Tumor response criteria for assessing Pazopanib therapy effect in metastatic renal cell carcinoma. Conference. 2018 Annual Meeting of the American Roentgen Ray Society. Washington, DC, US.
- 2017. Optimizing prostate cancer diagnostics: transperineal, transrectal and MRI-ultrasound fusion targeted biopsies. Invited. American Urological Association Annual Meeting 2017. Boston, MA, US.
- 2016. Challenges of solid tumor measurements and techniques to address this. Conference. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2016. Evaluation of solid tumor response criteria in assessing response to first-line pazopanib therapy in metastatic renal cell carcinoma. Conference. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2015. Challenges of solid tumor measurements and techniques to address this. Invited. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, TX, US.
- 2015. Prognostic value of newly proposed response criteria in assessing tumor response in advanced renal cell carcinoma. Invited. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2015. Optimizing prostate cancer diagnostics: transperineal, transrectal and MRI-ultrasound fusion targeted biopsies. Conference. American Urological Association's Annual Meeting 2015. New Orleans, LA, US.
- 2014. Challenges of solid tumor measurements and techniques to address this, RSNA refresher course program (ID: VSNM21-09). Invited. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2014. Radiologists and medical physicists: working together to achieve common goals in MR spectroscopy of prostate cancer. Conference. American Association of Physicists in Medicine 56th Annual Meeting and Exhibition. Austin, TX, US.
- 2014. Personalized prostate MRI - how we do. Conference. 114th Annual Meeting of the American Roentgen Ray Society. San Diego, CA, US.
- 2013. Atypical imaging presentations of focal nodular hyperplasia with radiologic pathologic correlation. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2013. Mucinous adenocarinoma of the rectum-limitations of routine high resolution MR staging. Conference. 99th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2013. What are the best response criteria (Choi vs RECIST)? PRO for Choi Criteria. Invited. 2013 Neuroendocrine Tumor Symposium Emerging Targets & Therapeutic Advances in NET Management. Charleston, SC, US.
- 2013. Non-invasive preoperative quantification of hepatic steatosis using a novel MRI technique: 100% accuracy confirmed with pathologic assessment. Conference. AHPBA Annual Meeting 2013. Miami Beach, FL, US.
- 2012. Strengths and limitations of extravascular and liver specific contrast agents in the evaluation of liver lesions. Conference. 98th Scientific Assembly & Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2012. Clinically relevant personalized prostate imaging: how do we do?. Conference. 98th Scientific Assembly & Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Key findings in rectal cancer with emphasis on 3 T MRI. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Exploration of the molecular mechanism of CT: evidence of response to imatinib in gastrointestinal stromal tumors. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Mucinous adenocarcinoma of the rectum: disease patterns and pitfalls. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Role of the high-resolution MRI in the presurgical evaluation of low rectal tumors. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Optimization of high-resolution MRI technique for pretreatment staging of the cervical and endometrial cancer. Conference. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2011. Preoperative MRI staging of rectal ca. Conference. American Roentgen Ray Society 2011 Annual Meeting. Chicago, IL, US.
- 2011. The use of dynamic contrast enhanced endorectal magnetic resonance imaging in the evaluation of patients with rising or persistently elevated PSA after radical prostatectomy. Conference. Cancer Imaging and Radiation Therapy Symposium 2011. Atlanta, GA, US.
- 2011. Feasibility of 3T magnetic resonance spectroscopic imaging of prostate using a perfluorocarbon compound filled endorectal coil. Conference. Department of Defense (DOD) Prostate Cancer Research Program: 2011 Innovative Minds in Prostate Cancer Today Conference. Orlando, FL, US.
- 2010. Preoperative staging of primary rectal tumors: roles of thin section multiplanar 2D T2 FSE imaging, 3D CUBE and diffusion-weighted imaging. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2010. Structured reporting for MRI staging of rectal cancer. Conference. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2010. Advanced imaging in prostate cancer. Conference. 5th Urologic Oncology: Advances in Clinical Practice. Houston, TX, US.
- 2010. A practical approach in detection of local recurrence of prostate cancer in the prostatectomy bed: use of slope images. Conference. 110th Annual Meeting of the American Roentgen Ray Society. San Diego, CA, US.
- 2009. Advantage of computed tomography for monitoring pulmonary metastases after surgery for soft tissue sarcoma. Conference. Connective Tissue Oncology Society 15th Annual Meeting. Miami, FL, US.
- 2009. A randomized, phase II study of perifosine (P) plus imatinib-resistant gastrointestinal stromal tumor (GIST). Conference. Connective Tissue Oncology Society 15th Annual Meeting. Miami, FL, US.
- 2008. Factors affecting, and possible ways for improving, the prostate MR spectroscopic quality: a single institution experience. Conference. 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2007. Responding or not responding? Lessons from GIST model. Invited. Annual Community Oncology Research Forum. Grapevine, TX, US.
- 2007. Utility of FIESTA sequence in day to day MRI imaging. Conference. 107th Annual Meeting of the American Roentgen Ray Society. Orlando, FL, US.
- 2005. Update additional faculty-recent data presented on the treatment of GIST. Invited. IMPACT Educators Workshop. Hollywood, FL, US.
- 2004. Use of perfluorocarbon in magnetic resonance spectroscopy (MRS) of prostate: a method to improve the linewidth and quality of spectra. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2004. Online tools for collaboration between radiologists and clinicians in a PACS environment. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2004. Gastrointestinal stromal tumor (GIST): role of CT in diagnosis, response evaluation, and surveillance after treatment with Imatinib. Conference. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2004. Comparison of treatment volumes and techniques in prostate cancer radiation. Poster. Conference. The American Radium Society Meeting. Napa Valley, CA, US.
- 2004. Time to revisit the tumor response evaluation criteria of GIST. Invited. Southwest Oncology Group Annual Meeting. Huntington Beach, CA, US.
- 2003. Development of new clinical practice guideline in management of gastrointestinal stromal tumor (GIST). Invited. National Comprehensive Cancer Network Annual Meeting. New York, NY, US.
- 2003. Correlation of CT and PET in patients with metastatic GIST treated at a single institution with Imatinib Mesylate on Intergroup Study S0033. Invited. Southwest Oncology Group Annual Meeting. San Diego, CA, US.
- 2002. Comparison of CT and MR perfusion parameters of metastatic tumors in the abdomen. Conference. 88th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2002. Monitoring treatment effects of STI-571 on gastrointestinal stromal tumors (GIST) with CT and PET: a quantitative analysis. Conference. 88th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2001. MRI of common and uncommon large pelvic masses. Conference. 87th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2000. Radiofrequency (RF) ablation of liver tumors: assessment of therapeutic response and complications. Conference. 86th Scientific Assembly and Annual Meeting of the Radiological Society of North America. Chicago, IL, US.
- 2000. Radiofrequency ablation of liver tumors: assessment of therapeutic response and complications - update. Conference. The Society of Surgical Oncology 53rd Annual Meeting. New Orleans, LA, US.
- 1985. Importance of renal depth correction in quantitation of differential renal function. Conference. 32nd Annual Meeting of the Society of Nuclear Medicine. Houston, TX, US.
International Presentations
- 2023. Magnetic Resonance Spectroscopy - application in prostate cancer. Invited. International Congress on MRI. Seoul, KR.
- 2022. Prostate Biopsy: MRI-Ultrasound Fusion-guided biopsy - Update. Invited. Asian Oceanian Congress of radiology & Korean Congress of Radiology. Seoul, KR.
- 2019. Prostate Biopsy: MRI-Ultrasound Fusion-guided biopsy. Invited. The 50th Korean Society of Ultrasound in Medicine. Seoul, KR.
- 2019. Liver MRI – Focal benign and malignant haptic lesions. Invited. The 1st Mongolian Society of Abdominal MRI. Ulaanbaatar, MN.
- 2019. Testicular ultrasound. Invited. The 50th Korean Society of Ultrasound in Medicine. Seoul, KR.
- 2018. Comparison of prostate volume measured by transrectal ultrasonography and magnetic resonance imaging with the actual prostate volume measured after radical prostatectomy. Conference. International Society for Magnetic Resonance in Medicine 27th Annual Meeting and Exhibition. Paris, FR.
- 2018. Scrotal imaging - Ultrasound. Invited. The 5th International Forum Genitourinary Imaging and Intervention. Ulaanbaatar, MN.
- 2018. MRI of prostate. Invited. The 5th International Forum Genitourinary Imaging and Intervention. Ulaanbaatar, MN.
- 2017. Computed tomography in abdominal oncology. Invited. First Central Hospital of Mongolia, Mongolian Society of Interventional Radiology - International Forum 2017. Ulaanbaatar, MN.
- 2017. Imaging rectal tumor magnetic resonance imaging. Invited. First Central Hospital of Mongolia, Mongolian Society of Interventional Radiology - International Forum 2017. Ulaanbaatar, MN.
- 2016. Controversies in liver cancers – assessment of tumour response after treatment: tumor response evaluation: mRECIST. Invited. 10th International Liver Cancer Association Annual Conference. Vancouver, CA.
- 2016. Clinical characteristics and treatment outcome in a large multicenter observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumor (GIST) patients. Conference. American Society of Clinical Oncology Annual Conference 2016. Chicago, US.
- 2016. Prostate MRSI with reduced acquisition time and improved multichannel spectral processing. Conference. International Society for Magnetic Resonance in Medicine 24th Annual Meeting and Exhibition. Singapore, SG.
- 2014. Personalized prostate imaging. Conference. MD Anderson Cancer Center - Global Academics Program Annual Meeting. Seoul.
- 2012. Surgical management issues in unresectable GIST - clinical case: imaging. Conference. Novartis, Oncology. Athens, GR.
- 2012. Biliary invasion of colorectal metastasis: Imaging evaluation. Invited. The Korean Society of Abdominal Radiology. Seoul, KR.
- 2011. Mechanism of early radiographic response to imatinib in GIST. Conference. American Society of Clinical Oncology Annual Meeting 2011. Chicago, US.
- 2010. Efficacy of neoadjuvant doxorubicin and ifosfamide (AI) in myxoid/round cell liposarcoma (MRCL): The M.D. Anderson Cancer Center experience (MDACC). Conference. 2010 American Society of Clinical Oncology Annual Meeting. Chicago, US.
- 2010. Response evaluation of the solid tumors at the era of personalized treatment: lessons from the GIST models. Invited. Chinese Taipei Society of Radiology and Asian Oceanian Society of Radiology. Taipei, TW.
- 2009. Recent imaging of submucosal tumors in GI tract. Invited. The Korean Congress of Radiology. Seoul, KR.
- 2009. New approaches in GIST management - clinical cases, expert forum. Invited. European CanCer Organisation 15 and 34th European Society for Molecular Oncology Multidisciplinary Congress. Berlin, DE.
- 2008. Combination therapy with temozolomide and bevacizumab (TMZ/BV) in the treatment of hemangiopericytoma/solitary fibrous tumor (HPC/SFT): an updated analysis. Conference. 14th Annual Meeting of the Connective Tissue Oncology Society. London, GB.
- 2008. Lessons from GIST model. Invited. Novartis Oncology South Pacific Summit. Phuket, TH.
- 2008. Responding or not responding: a lesson from GIST model. Invited. GIST Winter Workshop. Busan, KR.
- 2007. Changes in enhancement and morphology on CT imaging in hepatocellular carcinoma treated with bevacizumab and erlotinib. Conference. International Liver Cancer Association. Barcelona, ES.
- 2006. Operationalizing the Choi Criteria. Invited. 12th Annual Sarcoma Alliance for Research Through Collaboration-Connective Tissue Oncology Society Imaging Symposium. Venice, IT.
- 2006. Response of gastrointestinal stromal tumors (GISTs) to imatinib by Choi criteria and response evaluation criteria in solid tumors (RECIST) as surrogates for survival and time to progression. Conference. American Society of Clinical Oncology 42nd Annual Meeting. Atlanta, US.
- 2006. Quantitation of hepatic steatosis in oncologic patients using a fast dual-echo Dixon technique, 2nd Place Poster. Conference. International Society for Magnetic Resonance in Medicine 14th Scientific Meeting & Exhibition. Seattle, US.
- 2006. Effects of imatinib on tumor morphologic imaging. Invited. European Society for Medical Oncology International Symposium (EIS). Milan, IT.
- 2006. Managing technical factors affecting spectral quality of endorectal prostate MRS at 1.5T - Preliminary results. Conference. Society for MR Radiographers and Technologists 15th Annual Meeting. Seattle, US.
- 2004. The lessons of GIST: CT imaging sarcomas and assessing response to therapy. Invited. 10th Annual Sarcoma Alliance for Research Through Collaboration-Connective Tissue Oncology Society Imaging Symposium. Montreal, CA.
- 2004. PET in osteosarcoma: the correlation between percent necrosis and response as seen by PET. Conference. 10th Annual Meeting of Connective Tissue Oncology Society. Montreal, CA.
- 2004. Management of GIST with Glivec. Invited. International Glivec/Gleevec GIST Opinion Leader Summit. Paris, FR.
- 2004. Practical aspects of following patients with GIST. Invited. GIST Opinion Leader Summit. Paris, FR.
- 2004. Assessing tumor response in GIST - the role of PET and CT/MRI imaging. Invited. Korean GIST Workshop. Seoul, KR.
- 2004. Phase 1-2a dose ranging study of TLK286 (a novel glutathione analog) in combination with liposomal doxorubicin in platinum refractory or resistant ovarian cancer. Conference. American Society of Clinical Oncology Annual Meeting. New Orleans, US.
- 2004. Phase 1-2a study of TLK286 (a novel glutathione analog) in combination with carboplatin in platinum refractory or resistant (3rd line) ovarian cancer. Conference. American Society of Clinical Oncology Annual Meeting. New Orleans, US.
- 2004. Use of quantitative dynamic contrast MR imaging to monitor musculoskeletal sarcomas: correlation with FDG PET and pathology. Conference. E-poster. International Society for Magnetic Resonance in Medicine, 12th Annual Meeting. Kyoto, JP.
- 2004. Response evaluation of gastrointestinal stromal tumors (GIST). Invited. European Society for Medical Oncology/National Comprehensive Cancer Network Global Gastrointestinal Stromal Tumors (GIST) Consensus Group. Lugano, CH.
- 2004. A multidisciplinary approach: imaging gastrointestinal stromal tumors (GIST). Invited. Post Consensus Advisory Board. Lugano, CH.
- 2003. Should desist using Recist, at least in GIST. Invited. 8th Annual Meeting of the Connective Tissue Oncology Society. Barcelona, ES.
- 2003. Dynamic study of sarcoma with reduced-encoding imaging by generalized-series reconstruction. Conference. International Society for Magnetic Resonance in Medicine, 11th Annual Meeting. Toronto, CA.
- 2003. Silicone prosthesis imaging using an inversion recovery fast spin echo and fast Dixon technique. Conference. International Society for Magnetic Resonance in Medicine, 11th Annual Meeting. Toronto, CA.
- 2003. Correlation of CT and PET in patients with metastatic GIST treated at a single institution with Imatinib Mesylate. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
- 2001. Ablation par radiofrequence des tumeurs hepatiques: evaluation radiographique de la reponse therapeutique et des complications. Conference. 49e Journees Francaises de radiologie. Paris, FR.
- 2001. The role of CT design measurement to monitor the gastrointestinal stromal tumors after treatment with STI-571: a quantitative analysis. Conference. American Chiropractic College of Radiology - National Cancer Institute - European Organisation for Research and Treatment of Cancer International Conference. Miami Beach, US.
Formal Peers
- 2019. Imaging Solid Tumor Response - Current Challenges. Visiting. Seoul, KR.
- 2018. Scrotal Imaging - Ultrasound. Visiting. Ulaanbaatar, MN.
- 2018. MRI of Prostate. Visiting. Ulaanbaatar, MN.
- 2017. Imaging Rectal Tumor Magnetic Resonance Imaging. Ulan Bator, MN.
- 2017. Computed Tomography in Abdominal Oncology. Ulan Bator, MN.
- 2015. Response evaluation of solid tumors: Imaging biomarkers. Visiting. Goyang-si, Gyeonggi-do, KR.
- 2014. Challenges of solid tumor measurements and techniques to address this. Invited. Chicago, IL, US.
- 2014. The Promise of Imaging Biomarkers for the Assessment of Treatment Response. Visiting. Houston, TX, US.
- 2014. Integration of MRI in oncology - prostate cancer. Invited. Ilsandong-gu, KR.
- 2014. Imaging prostate cancer. Visiting. Goyang-si, Gyeonggi-do, KR.
- 2013. Response Evaluation of Solid Tumors “Image Biomarker”. Visiting. Houston, TX, US.
- 2013. The methods other than RECIST that have been developed to judge tumor response in GIST. Invited. Istanbul, TR.
- 2012. Biliary invasion of colorectal metastasis: Imaging evaluation. Invited. Seoul, KR.
- 2012. Response evaluation of solid tumors – Choi Criteria. Invited. Seoul, KR.
- 2010. Response evaluation of solid tumors at the era of molecularly Targeted Treatment: Lesson from the GIST model. Invited. Daejon, KR.
- 2008. Response valuation of solid tumors: Lessons from the GIST model. Invited. Seoul, KR.
- 2005. The era of molecular therapy: redefining the treatment of gastrointestinal stromal tumors (GIST),. Wheeling, WV, US.
- 2005. The era of molecular therapy: redefining the treatment of gastrointestinal stromal tumors (GIST),.
- 2004. Grand Rounds - Functional imaging for monitoring targeted therapy in solid tumors. Response evaluation of GIST treated with Imatinib: time to revisit the response criteria. Houston, Texas, US.
Grant & Contract Support
| Date: | 2014 - 2020 |
| Title: | Development of Optimized 3T MRSI of prostate without use of an endorectal coil |
| Funding Source: | GE Healthcare |
| Role: | PI |
| ID: | 2011-0542-10 |
| Date: | 2013 - 2022 |
| Title: | Repeatability assessment of quantitative DCE‐MRI and DWI: a multicenter study of functional imaging standardization in the prostate |
| Funding Source: | ACRIN |
| Role: | PI |
| ID: | ACRIN 6701 |
| Date: | 2013 - 2016 |
| Title: | Clinical and technical ceasibility of a ultrasuperparamagnetic nanoparticle iron oxide (USPIO)-enhanced magnetic resonance lymph node imaging |
| Funding Source: | DICRC |
| Role: | PI |
| ID: | 2012-0926 |
| Date: | 2012 - Present |
| Title: | Evaluation of synthetic MRI sequence in body imaging |
| Funding Source: | GE Health Care |
| Role: | PI |
| ID: | 2011-0542-03 |
| Date: | 2007 - 2019 |
| Title: | 3T perfluorocarbon-filled endorectal magnetic resonance spectroscopic imaging of prostate carcinoma |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| ID: | W81XWH-07-1-0110 |
| Date: | 2007 - 2020 |
| Title: | Validation study of magnetic resonance elastrography and 2-point dixon MR imaging techniques in diffuse liver disease |
| Funding Source: | Diagnostic Imaging, MD Anderson Cancer Center |
| Role: | PI |
| ID: | 2007-0107 |
| Date: | 2006 - 2013 |
| Title: | Feasibility study of 3T endorectal magnetic resonance spectroscopic imaging (MRSI) of prostate |
| Funding Source: | GE Healthcare |
| Role: | PI |
| ID: | 2006-0333 |
| Date: | 2004 - 2006 |
| Title: | A validation study of MR lymphangiography using SPIO, a new lymphotrophic superparamagnetic nanoparticle contrast |
| Funding Source: | Advanced Magnetics, Inc |
| Role: | PI |
| ID: | CS2004-00011994LE |
| Date: | 2003 - 2007 |
| Title: | ACRIN core agreement and s/c agreements |
| Funding Source: | ACRIN |
| Role: | Project Leader |
| ID: | 5 U01 CA080098 05 |
| Date: | 2003 - 2007 |
| Title: | MR imaging and MR spectroscopic imaging of prostate cancer prior to radical prostatectomy: a prospective multi-institutional clinicopathological study |
| Funding Source: | ACRIN |
| Role: | Principal Investigator-MDACC |
| ID: | 5 U01 CA080098 04 |
| Date: | 2002 |
| Title: | Feasibility study of magnetic resonance choledochopancreaticography (MRCP) using a new ultra-fast MR imaging technique: FIESTA |
| Funding Source: | GE Healthcare |
| Role: | PI |
| ID: | ID02-640 |
| Date: | 2002 - 2007 |
| Title: | Comparative evaluation of isomolar nonionic contrast (Visipaque) and hyperosmolar nonionic contrast (Optiray) in the detection of hypovascular liver metastasis |
| Funding Source: | GE Healthcare |
| Role: | PI |
| ID: | CS2002-00006779SM 01 |
| Date: | 2002 - 2003 |
| Title: | Evaluation of tumor angiogenesis and viability using functional MR imaging techniques in hematological malignancies |
| Funding Source: | Mike Hogg Fund |
| Role: | PI |
| Date: | 2002 - 2003 |
| Title: | Exploration of utility of functional MR imaging and MR spectroscopy in managing the prostate carcinoma |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| ID: | IDO1-695 |
| Date: | 2002 |
| Title: | Comparative evaluation of isosmolar nonionic contrast (Visipaque) and hyperosmolar nonionic contrast (Optiray) in the detection of hypovascular liver metastasis |
| Funding Source: | Amersham Healthcare |
| Role: | PI |
| ID: | CS2002-00006779-01 |
| Date: | 2001 - 2002 |
| Title: | Probing tissue cellular properties using diffusion magnetic resonance imaging |
| Funding Source: | The University of Texas MD Anderson Cancer Center Institutional Research Grant |
| Role: | Investigator |
| Date: | 2001 - 2003 |
| Title: | Functional MR imaging to assess tumor viability and angiogenesis in locally invasive prostate carcinoma |
| Funding Source: | The University of Texas MD Anderson Cancer Center Institutional Research Prostate Spore Grant |
| Role: | Investigator |
| ID: | ID01-263 |
Patient Reviews
CV information above last modified May 02, 2025